Kynamro (Mipomersen)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kynamro (Mipomersen), covering 2013-03-20 to 2013-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients [Phase 3]